On April 2, the European Parliament voted overwhelmingly to repeal the current EU Directive on clinical trials of medicinal products for human use and replace it with a new Regulation. The primary goals of the new Regulation are to:
- Streamline the approval process for studies conducted across multiple Member states;
- Harmonize the regulation of clinical trials throughout the Member states; and
- Increase transparency of Clinical Trial results.
It was the European Parliament's hope that accomplishing the first two goals would increase the number of clinical ...
Blog Editors
Recent Updates
- Breaking Down the Legal Challenges Surrounding State Licensure Restrictions for Telehealth Providers
- Interested in Opening a Medical Spa? Here’s What You Need to Know
- Podcast: Key Changes in Finalized Antitrust Merger Guidelines – Diagnosing Health Care
- FDA Releases Draft Guidance on New Dietary Ingredient Notification Master Files for Dietary Supplements
- Updated Requirements for Informed Consent: HHS Issues New Guidance on Sensitive Exams